ERVW-1 and infection: Extended analysis of this HIV vaccine trial showed that it is the vaccine trial to succeed in eliciting IgG antibodies to the V1V2 region of Env, and the presence of these antibodies were inversely correlated to the rate of infection [10], suggesting an importance to elicit anti HIV-1 specific antibodies.